PolicyWinds
Topic and direction labels are AI-assisted, and each one quotes the bill text it is based on. How labels work
New York · 2025-2026 General Assembly

S00036 Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.

Direction

Abortion medication abortionAI label

Expands abortion access model confidence 80%

Allows prescription labels for mifepristone and misoprostol to use a health care practice name instead of the individual prescriber or dispenser name at the prescriber's request, which can reduce privacy and safety risks for providers of medication abortion and thereby facilitate greater access.

at the prescriber's request, the prescription label for mifepristone, misoprostol, and their generic alternatives may include the name of the prescribing health care practice instead of the name of the prescriber.

✓ Quote verified word for word in the bill text

Abortion provider clinic regulationAI label

Expands abortion access model confidence 70%

Permits prescription labels for mifepristone and misoprostol to substitute a health care practice name for the individual prescriber or dispenser name, easing certain labeling requirements for providers of medication abortion.

Notwithstanding subdivision one of this section, at the prescriber's request, the prescription label for mifepristone, misoprostol, and their generic alternatives may include the name of the prescribing health care practice instead of the name of the prescriber.

✓ Quote verified word for word in the bill text

  1. Filed (completed)
  2. Committee (completed)
  3. Passed one chamber (completed)
  4. Passed both (completed)
  5. Governor (completed)
  6. Law

Stage: Law · step 6 of 6

Last action
2025-02-03: APPROVAL MEMO.1
Filed
2025-01-08
Sponsor
Shelley Mayer D + 5 cosponsors (5 D)

Why the model tagged it this way: The bill addresses medication abortion by amending labeling rules specifically for mifepristone, misoprostol, and generics to allow practice names in place of individual prescriber/dispenser names, which protects provider privacy and supports access; this fits abortion/medication-abortion and abortion/provider-clinic-regulation as an easing of regulation that expands access.

Related bills

Hearings and calendar

Votes

DateChamberMotionYea-Nay
2025-01-21SSenate Floor Vote - Final Passage39-20Passed
2025-01-21SSenate Rules Committee Vote13-6Passed
2025-01-22AAssembly Floor Vote - Final Passage95-42Passed

Sponsors

Text versions

History (15 actions)
DateChamberAction
2025-02-03SAPPROVAL MEMO.1
2025-02-03SSIGNED CHAP.7
2025-02-03SDELIVERED TO GOVERNOR
2025-01-22Areturned to senate
2025-01-22Apassed assembly
2025-01-22Aordered to third reading rules cal.61
2025-01-22Asubstituted for a2145a
2025-01-21Areferred to higher education
2025-01-21SDELIVERED TO ASSEMBLY
2025-01-21SPASSED SENATE
2025-01-21SORDERED TO THIRD READING CAL.99
2025-01-21SCOMMITTEE DISCHARGED AND COMMITTED TO RULES
2025-01-13SPRINT NUMBER 36A
2025-01-13SAMEND (T) AND RECOMMIT TO HIGHER EDUCATION
2025-01-08SREFERRED TO HIGHER EDUCATION